Retrospective Study
Copyright ©The Author(s) 2016.
World J Gastroenterol. Apr 28, 2016; 22(16): 4219-4225
Published online Apr 28, 2016. doi: 10.3748/wjg.v22.i16.4219
Table 1 Demographic and clinical characteristics of patients
Characteristicn
Sex
Male369
Female231
Admission symptoms
Melena423
Hematemesis142
Hematochezia76
Syncope34
Systolic blood pressure (mmHg)
< 9026
90-139546
≥ 14028
Diastolic blood pressure (mmHg)
< 6055
60-89539
≥ 906
Heart rate (bpm)
< 602
60-100448
> 100150
Respiratory rate (rpm)
12-20545
> 2055
Oxygen saturation (%)
< 9214
≥ 92586
Glasgow coma score
< 1521
15579
Table 2 Upper endoscopy results, treatment modalities and mortality rates
Forrest classification[4]n (%)Medical treatmentEndoscopic treatment1SurgeryAngiographic embolizationExitus
Spurting hemorrhage (1a)41 (12.2)039020
Oozing hemorrhage (1b)41 (12.2)039202
Visible vessel (2a)16 (4.8)213101
Adherent clot (2b)16 (4.8)59201
Flat pigmented hematin on ulcer base (2c)3 (0.9)30000
Lesions without signs of recent hemorrhage/fibrin-covered clean ulcer base (3)218 (65.1)216022023
Total335 (100)226100726
Table 3 Colonoscopy findings, treatment modality, and mortality rates
Colonoscopic findingsn (%)Active bleeding- +Medical treatmentEndoscopic treatmentSurgeryAngiographic embolizationExitus
Normal findings20 (44.4)2001900011
Anal pathologies9 (20.0)9070200
Recto-sigmoid pathologies7 (15.6)5250110
Other colon pathologies4 (8.9)3131010
Other pathologies5 (11.1)5041000
Total45 (100)423382321
Table 4 Laboratory results and treatment modalities
Medical treatmentEndoscopic treatmentAngiographic embolizationSurgeryP value
Hb (g/dL)9.929.748.328.850.283
Htc (g/dL)29.1228.6124.8225.850.273
Thrombocytes (103/L)251.59272.61282.40291.950.162
BUN (mg/dL)38.5737.7333.6035.060.177
Creatinine (mg/dL)1.151.071.171.070.864
Glucose, (mg/dL)144.25148.50173.40164.050.539
AST (IU/L)33.5924.3366.2059.750.635
ALT (IU/L)26.1020.2162.8029.250.825
aPTT (s)31.3626.9231.8026.830.818
INR (s)2.221.592.402.250.831
Mean blood pressure (mmHg)83.7481.4775.3372.830.001
Pulse (bpm)91.8195.04108.0098.050.043
Table 5 Comparison of laboratory results according to departments of admission
General wards/EDICUP value
Hb (g/dL)9.898.820.051
Htc (g/dL)29.0425.960.054
Thrombocytes (103/L)254.87298.880.086
BUN (mg/dL)36.8637.380.909
Creatinine (mg/dL)1.131.180.787
Glucose (mg/dL)144.53171.470.050
AST (IU/L)33.21106.590.131
ALT (IU/L)24.6388.810.238
aPTT (s)30.5728.360.402
INR (s)2.112.610.370
Mean blood pressure (mmHg)83.0979.110.097
Pulse (bpm)92.7393.560.803
SpO2 (%)95.1694.960.467
Table 6 Comparison of laboratory results for surviving and exitus patients
SurvivingExitusP value
Hb (g/dL)9.859.630.072
Htc (g/dL)28.9028.540.085
Thrombocytes (103/L)259.06230.050.280
BUN (mg/dL)36.2446.390.016
Creatinine (mg/dL)1.101.650.038
Glucose (mg/dL)144.56166.760.268
AST (IU/L)33.0697.290.150
ALT (IU/L)26.5350.580.061
aPTT (s)30.4530.430.991
INR (s)2.181.990.072
Mean blood pressure (mmHg)83.2876.920.004
Pulse (bpm)92.5196.680.175
SpO2 (%)95.1894.630.049
Table 7 Comparison of surviving and exitus patient history, need for transfusion, and mortality n (%)
SurvivingExitusP value
Medical history562 (93.7)38 (6.3)
Liver disease
+42 (87.5)6 (12.5)0.730
-520 (94.2)32 (5.8)
Peptic ulcer
+62 (100)0 (0.0)0.014
-500 (92.9)38 (7.1)
Malignancy
+64 (84.2)12 (15.8)0.001
-498 (95.0)26 (5.0)
Bleeding diathesis
+7 (100)0 (0.0)0.631
-555 (93.6)38 (6.4)
Anal disease
+9 (100)0 (0.0)0.553
-553 (93.6)38 (6.4)
Hypertension
+164 (96.5)6 (3.5)0.051
-398 (92.6)32 (7.4)
Diabetes mellitus
+86 (92.5)7 (7.5)0.373
-476 (93.9)31 (6.1)
Coronary artery disease
+85 (93.4)6 (6.6)0.530
-477 (93.7)32 (6.3)
Comorbid disease
+77 (96.3)3 (3.8)0.227
-485 (93.3)35 (6.7)
ES replacement
+291 (93.3)21 (6.7)0.400
-271 (94.1)17 (5.9)
FFP replacement
+106 (92.2)456 (94)0.290
-9 (7.8)29 (6.0)
GCS
15549 (94.8)30 (5.2)0.000
< 1513 (61.9)8 (38.1)
Table 8 Causes of mortality
Causes of mortalityn (%)
Malignancy114 (36.8)
Esophageal varices bleeding8 (21.1)
Sepsis/septic shock6 (15.8)
Renal failure4 (10.5)
Multi organ failure3 (7.9)
Others23 (7.9)
Total38 (100)